2016
DOI: 10.1039/c6ay02158a
|View full text |Cite
|
Sign up to set email alerts
|

Portable point-of-care diagnostic devices

Abstract: This review highlights key development of point-of-care diagnostics for detecting DNA, proteins, bacteria/pathogens, and other species in samples that can be used for diagnosing disease and detecting harmful chemical and biochemical contaminants in samples. These technologies have great promise for improving the quality of life for those in the developing world.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
29
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(29 citation statements)
references
References 136 publications
0
29
0
Order By: Relevance
“…1214 Among its potential uses for different disease diagnosis, prototypes to elucidate cancer cell and tumor function have gained tremendous importance. 15, 16 Microfluidic-based analyzers for cell biomechanical screening and mechanophenotyping have promised a higher throughput compared to conventional tools and emerged as a clinically more relevant approach to single-cell analysis.…”
Section: Introductionmentioning
confidence: 99%
“…1214 Among its potential uses for different disease diagnosis, prototypes to elucidate cancer cell and tumor function have gained tremendous importance. 15, 16 Microfluidic-based analyzers for cell biomechanical screening and mechanophenotyping have promised a higher throughput compared to conventional tools and emerged as a clinically more relevant approach to single-cell analysis.…”
Section: Introductionmentioning
confidence: 99%
“…The real-time virus detection has a high interest in various fields, such as biosecurity, biomedicine, and environmental science [104]. Nanosensor does not need trained personnel and expensive equipment, especially if obtained results can be read by naked eyes [105,106].…”
Section: Other Virusesmentioning
confidence: 99%
“…To realize the full potential of POCT systems, both the speed and convenience of biosensing systems or device must be optimized [1][2][3]. Clinical diagnostics, for example, typically require long assay times and would benefit from immediately testing and diagnostics at the patient's site [1,[4][5][6]. Furthermore, in the case of cancer metastasis, it has been reported that circulating tumor cells (CTC) and excreted vesicles (50-150 nm in size) known as exosomes which have infiltrated the blood vessels can be measured and correlated to the level of metastasis [7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%